• Presentations, 2014

in page functions
  • Presentations from 2014 explaining the work, progress and achievements of the Vaccine Alliance.

  • 10 December 2014

    CEO Board Report December 2014

    Topics covered include: Key events and updates ; Vaccine introductions ; Broader landscape ; Resource mobilisation ; Coverage and equity ; Risk management ; Going forward.

    28 October 2014

    Pentavalent: 1 vaccine, 5 diseases, 73 countries

    The 5-in-1 pentavalent vaccine is now available in all Gavi-supported countries at a record low price, but  only 50% of the children are being reached. Learn more about the pentavalent success story – and the challenges that remain.

    27 October 2014

    Immunisation progress in Asia-Pacific

    Presentation on immunisation in Asia-Pacific, including support for pentavalent, pneumococcal, measles, rubella, HPV, Japanese encephalitis, hepatitis B and inactivated polio vaccines, the growing number of manufacturers of Gavi-funded vaccines based in  the region, and the increasing co-financing contributions by countries. Despite this progress, challenges remain: almost half of the world’s under-immunised children are in Gavi-supported countries in Asia-Pacific.

    01 October 2014

    Economic benefits of vaccines

    This short presentation sets out the growing body of evidence to show the economic impact of vaccination through direct and indirect cost savings, as well as contributions to the broader economy.

close icon

modal window here